UG»·Çò

ÄúÏÖÔÚµÄλÖãº ÍøÕ¾Ê×Ò³ >×éѧЧÀÍ

UG»·Çò¡¤(ÖйúÇø)¹Ù·½ÍøÕ¾

±í¹Û×é

ÏÖ¼Ûѯ¼Û

²úÆ·ÏêÇé

È«»ùÒò×é¼×»ù»¯
 

È«»ùÒò×é¼×»ù»¯²âÐò£¨Whole Genome Bisulfite Sequencing£¬£¬£¬£¬WGBS£©Êǽ«ÖØÑÇÁòËáÑΣ¨Bisulfite£©´¦Öóͷ£ÒªÁìºÍIllumina¸ßͨÁ¿²âÐòÏàÁ¬Ïµ£¬£¬£¬£¬¶ÔÓвο¼»ùÒò×éÐÅÏ¢µÄÎïÖÖ¾ÙÐÐÈ«»ùÒò×鹿ģÄڵļ׻ù»¯Ë®Æ½¼ì²â¡£¡£¡£¡£¡£¡£WGBS¿ÉÒÔ׼ȷµ½µ¥¼î»ùÇø·ÖÂÊ£¬£¬£¬£¬×¼È·ÆÊÎöÿһ¸öC¼î»ùµÄ¼×»ù»¯×´Ì¬£¬£¬£¬£¬¿ÉÒÔµÖ´ïÈ«»ùÒò×éÁýÕÖ, ÊÇÑо¿¼×»ù»¯Ë®Æ½µÄ“½ð±ê×¼”¡£¡£¡£¡£¡£¡£WGBSÖª×ãÈ«»ùÒò×é¼×»ù»¯Í¼Æ×¡¢¼²²¡¹ØÁªÆÊÎö¡¢»ùÒòµ÷¿ØÆÊÎö¡¢¼²²¡µÄ¼×»ù»¯±ê¼ÇÎïɸѡµÈ̽Ë÷ÐÔ¿ÎÌâÑо¿¡£¡£¡£¡£¡£¡£
 
ÉúÎïÐÅϢѧÆÊÎöÄÚÈÝ

UG»·Çò¡¤(ÖйúÇø)¹Ù·½ÍøÕ¾


 

¼ò»¯¼×»ù»¯²âÐòRRBS
 

¼ò»¯¼×»ù»¯²âÐò£¨Reduced Representation Bisulfite Sequencing£¬£¬£¬£¬RRBS£©Í¨¹ýøÇи»¼¯Æô¶¯×Ó¼° CpG µºÇøÓò£¬£¬£¬£¬²¢¾ÙÐÐ Bisulfite ²âÐò£¬£¬£¬£¬Í¬Ê± ʵÏÖ DNA ¼×»ù»¯×´Ì¬¼ì²âµÄ¸ßÇø·ÖÂʺͲâÐòÊý¾ÝµÄ¸ßʹÓÃÂÊ¡£¡£¡£¡£¡£¡£×÷ΪһÖÖ¸ßÐԼ۱ȵļ׻ù»¯Ñо¿ÒªÁ죬£¬£¬£¬¼ò»¯¼×»ù»¯²âÐòÔÚ´ó¹æÄ£ ÁÙ´²Ñù±¾µÄÑо¿ÖоßÓÐÆÕ±éµÄÓ¦ÓÃÔ¶¾°¡£¡£¡£¡£¡£¡£


 

MeRIP-seq
 

ÔÚת¼ºóÐÞÊÎÖУ¬£¬£¬£¬N6-¼×»ùÏÙàÑßÊ£¨N6-methyladenosine, m6A£©ÊÇmRNAºÍlncRNAsÉÏ×îΪÆÕ±éµÄÐÞÊÎÖ®Ò»¡£¡£¡£¡£¡£¡£ÏÖÔÚ·¢Ã÷microRNA£¬£¬£¬£¬circRNA, rRNA, tRNAºÍsnoRNAÉ϶¼ÓÐm6AÐÞÊΡ£¡£¡£¡£¡£¡£m6AÐÞÊÎÖ÷Òª±¬·¢ÔÚRRACHÐòÁÐÖеÄÏÙàÑßÊÉÏ£¬£¬£¬£¬Æä¹¦Ð§Ö÷ÒªÓÉWriter¡¢EraserºÍReader¾öÒé¡£¡£¡£¡£¡£¡£Writer¼´¼×»ù×ªÒÆÃ¸£¬£¬£¬£¬ÏÖÔÚÒÑÖªÕâ¸ö¸´ºÏÎïµÄÒòËØÓÐMETTL3£¬£¬£¬£¬METTL14, METTL16, WTAPºÍKIAA1429µÈ¡£¡£¡£¡£¡£¡£¶øALKBH5ºÍFTO×÷Ϊȥ¼×»ùø£¨Eraser£©¿ÉÄæ×ª¼×»ù»¯¡£¡£¡£¡£¡£¡£ÏÖÔÚ·¢Ã÷m6AÁ¬ÏµÂѰף¨Reader£©ÓÐYTH½á¹¹ÓòÂѰף¨YTHDF1, YTHDF2,YTHDF3,YTHDC1ºÍYTHDC2£©ºÍºË²»¾ùÒ»ÂѰ×HNRNP¼Ò×壨HNRNPA2B1ºÍ HNRNPC£©¡£¡£¡£¡£¡£¡£

MeRIP-seqÔòÊÇÑо¿m6AÐÞÊÎÇ¿ÓÐÁ¦µÄÊÖÒÕÖ®Ò»¡£¡£¡£¡£¡£¡£MeRIP-seqÊǽ«MeDIP¡¢RIP¼°RNA-seqÊÖÒÕÁ¬ÏµÆðÀ´£¬£¬£¬£¬ÔÚÈ«»ùÒò×鹿ģÄÚ¼ì²âRNA¼×»ù»¯¡£¡£¡£¡£¡£¡£Ê¹ÓÃÌØÒìÐÔµÄRNA¼×»ù»¯¿¹Ìå¾ÙÐÐÃâÒß¹²³Áµí·´Ó¦£¬£¬£¬£¬½«»ñµÃµÄ¼×»ù»¯ÐÞÊÎÆ¬¶Ï¾ÙÐвâÐò£¬£¬£¬£¬Í¬Ê±£¬£¬£¬£¬Éè¼ÆInput±ÈÕÕÑù±¾Ïû³ýÅä¾°¡£¡£¡£¡£¡£¡£

ÊÖÒÕÓÅÊÆ

ЯÊÖRNA¼×»ù»¯Ñо¿¹ú¼Ê×ÅÃûÍŶÓ£¬£¬£¬£¬Éî¶ÈÓÅ»¯ÊµÑéÓëÆÊÎöÁ÷³Ì£»£»£»
ÌáÁ¶Êýʮƪ¶¥¼¶RNA¼×»ù»¯ÎÄÕÂ˼Ð÷£¬£¬£¬£¬Á¿Éí¶¨ÖÆÇ°ÑØÊµÑ鼯»®£»£»£»
Ìṩ¶à×éѧÕûºÏÆÊÎöÓ빦ЧÑé֤һվʽЧÀÍ£¬£¬£¬£¬´ó·ùËõ¶ÌʵÑéÖÜÆÚ£»£»£»
Ò»Á÷µÄÊý¾ÝÍÚ¾òÍŶÓ+¸»ºñµÄÂÛÎÄÉó¸åÂÄÀú£¬£¬£¬£¬¼ÓËÙ¿ÆÑÐЧ¹û½ÒÏþ¡£¡£¡£¡£¡£¡£ 

 
Ñù±¾ÆðʼÁ¿ÓëËÍÑù½¨Òé

Ñù±¾ÀàÐÍ ÆðʼÁ¿
ϸ°û >5x106
¶¯Îï×éÖ¯ >100 mg
Ö²Îï >5 g
 
×¢ÖØÊÂÏÏêϸÑù±¾×¼±¸Ö¸ÄÏ£¬£¬£¬£¬ÇëÁªÏµÔÚÏ߿ͷþ¡£¡£¡£¡£¡£¡£

ÆÊÎöÄÚÈÝ

1. ²âÐòÐòÁÐͳ¼ÆÓëÖÊ¿Ø
2. ²Î¿¼»ùÒò×é±È¶Ô£º²Î¿¼»ùÒò×é±È¶ÔReadsͳ¼Æ¡¢²Î¿¼»ùÒò×é±È¶ÔÇøÓòÂþÑÜ¡¢²âÐòÊý¾Ý±È¶ÔÂþÑÜ
3. È«»ùÒò×éPeakɨÃ裺Peak calling¡¢Peak×¢ÊÍ
4. ²î±ðPeakÆÊÎö£º²î±ðPeakÐÅϢͳ¼Æ¡¢²î±ðPeak»ùÒòGO¸»¼¯ÆÊÎö¡¢²î±ðPeak»ùÒòKEGG¸»¼¯ÐÔÆÊÎö
5. MotifÆÊÎö

 
°¸Àýչʾ

¿Í»§°¸Àý1£ºm6Aµ÷¿ØmiRNA³õ¼¶Ìåʶ±ð¼Ó¹¤

ÂÛÎÄÎÊÌ⣺N6-methyl-adenosine (m6A) marks primary microRNAs for processing
¿¯µÇÈÕÆÚ£º2015Äê03ÔÂ
½ÒÏþÔÓÖ¾£ºNature
Ó°ÏìÒò×Ó£º40.1
Ñо¿»ú¹¹£ºÃÀ¹úÂå¿Ë·ÆÀÕ´óѧ

ÔÚmiRNAÉúÎïºÏ³ÉµÄµÚÒ»²½ÊÇÔÚ΢´¦Öóͷ£ÂѰ׸´ºÏÎïµÄ×ÊÖú϶Գõ¼¶microRNA£¨pri-miRNA£©¾ÙÐмӹ¤¡£¡£¡£¡£¡£¡£Î¢´¦Öóͷ£ÂѰ׸´ºÏÎïÓÉRNAÁ¬ÏµÂѰ×DGCR8ºÍIIIÐͺËÌǺËËáøDrosha×é³É¡£¡£¡£¡£¡£¡£Õâ¸öÆðʼÊÂÎñÐèÒªDGCR8ʶ±ðpri-miRNA·¢¼ÐÉϾ¥ºÍ²àÒíµ¥Á´RNAµÄÅþÁ¬´¦£¬£¬£¬£¬²¢ÕÐļDrosha¼ôÇÐË«Á´RNA±¬·¢Ç°ÌåmiRNA£¨pre-miRNA£©¡£¡£¡£¡£¡£¡£pri-miRNAµÄ¼Ó¹¤»úÖÆÒѾ­±»²ûÊÍ£¬£¬£¬£¬¿ÉÊÇÏÖÔÚ²¢²»ÖªµÀDGCR8ÔÚÖÚ¶à¾ßÓжþ¼¶½á¹¹µÄת¼±¾ÖÐʶ±ðºÍÁ¬Ïµpri-miRNAµÄ»úÖÆ¡£¡£¡£¡£¡£¡£

±¾Ñо¿ÖУ¬£¬£¬£¬Âå¿Ë·ÆÀÕ´óѧDr.Tavazoie½ÌÊÚ·¢Ã÷ÔÚ²¸È鶯Îïϸ°ûÖУ¬£¬£¬£¬METTL3»áʹpri-miRNA±¬·¢¼×»ù»¯£¬£¬£¬£¬±ê¼ÇµÄpri-miRNA¿ÉÒÔ±»DGCR8µÄʶ±ðºÍ¼Ó¹¤¡£¡£¡£¡£¡£¡£Í¨¹ýmiRNAоƬÆÊÎö·¢Ã÷£¬£¬£¬£¬ÇõÍMETTL3»á½µµÍDGCR8Óëpri-miRNAµÄ½áÏàÖúÓ㬣¬£¬£¬ÒýÆð³ÉÊìÌåmiRNA±í´ïÁ¿½µµÍ£¬£¬£¬£¬Í¨¹ýδ¾­¼Ó¹¤pri-miRNAº¬Á¿ÔöÌí¡£¡£¡£¡£¡£¡£ÌåÍâʵÑé֤ʵm6A»áÔö½øpri-miRNAµÄ¼Ó¹¤¡£¡£¡£¡£¡£¡£×îºó£¬£¬£¬£¬¹¦Ð§Ñé֤ʵÑéÕ¹ÏÖMETTL3Äܹ»´ÙʹmiRNA³ÉÊì¡£¡£¡£¡£¡£¡£ÒÔÊÇm6A±ê¼ÇÊÇÒ»¸öÒªº¦µÄת¼ºóÐÞÊΣ¬£¬£¬£¬»áÔö½ømiRNAÉúÎïºÏ³ÉµÄÆðʼ¡£¡£¡£¡£¡£¡£

¿Í»§°¸Àý2£ºm6Aʶ±ðøHNRNPA2B1½éµ¼RNA¼Ó¹¤

ÂÛÎÄÎÊÌ⣺HNRNPA2B1 Is a Mediator of m6A-Dependent Nuclear RNA Processing Events
¿¯µÇÈÕÆÚ£º2015Äê09ÔÂ
½ÒÏþÔÓÖ¾£ºCell
Ó°ÏìÒò×Ó£º30.4
Ñо¿»ú¹¹£ºÃÀ¹úÂå¿Ë·ÆÀÕ´óѧ

ÒÑÖªm6AÊÇmRNAÖÐ×îÆÕ±éµÄÒ»ÖÖÄÚ²¿ÐÞÊη½·¨Ö®Ò»¡£¡£¡£¡£¡£¡£ÖÖÖÖתÂÇÀ¾ÈçmRNA¡¢lncRNAµÈÉÏЯ´øµÄm6AÐÞÊÎÄܹ»Ó°ÏìRNAÔÚϸ°ûºËÖеēÔËÆø”ÈçRNA½µ½âÒÔ¼°×ªÂ¼ºó¼Ó¹¤µÈ¡£¡£¡£¡£¡£¡£Âå¿Ë·ÆÀÕ´óѧDr.Tavazoie½ÌÊÚÔÚÎÄÖÐÑéÖ¤ÁËÒ»ÖÖRNAÁ¬ÏµÂѰ×HNRNPA2B1Äܹ»ÌØÒìÐÔʶ±ðת¼±¾ÉϵÄm6AÐÞÊΡ£¡£¡£¡£¡£¡£ÕâЩ±¬·¢m6AÐÞÊεÄλµãËùÔÚµÄmotifÓë¼×»ù»¯×ªÒÆÃ¸METTL3 motifÏàÆ¥Åä¡£¡£¡£¡£¡£¡£±ðµÄHNRNPA2B1Äܹ»Ö±½ÓÓ뱬·¢m6AÐÞÊεÄmiRNA³õ¼¶Ì壨pri-miRNA£©ÏàÁ¬Ïµ£¬£¬£¬£¬ÓëmiRNA΢´¦Öóͷ£ÂѰ׸´ºÏÎïÖ®Ò»DGCR8Ò»Æð´Ùʹpri-miRNA³ÉÊìÌåµÄ¼Ó¹¤¡£¡£¡£¡£¡£¡£

 
²Î¿¼ÎÄÏ×

1. Alarcón C R, Lee H, Goodarzi H, et al. N6-methyl-adenosine (m6A) marks primary microRNAs for processing[J]. Nature, 2015, 519(7544):482.
2. Alarcón C R, Goodarzi H, Lee H, et al. HNRNPA2B1 Is a Mediator of m(6)A-Dependent Nuclear RNA Processing Events.[J]. Cell, 2015, 162(6):1299-1308.
 
³£¼ûÎÊÌâ
1.Ñù±¾´¦Öóͷ£ÓÐÊ²Ã´ÌØÊâµÄÒªÇóÂ𣿣¿

Ñù±¾´¦Öóͷ£ÒªÁìÆ¾Ö¤ÊµÑéÊÒÊÇ·ñÓÐÒºµª·ÖΪÈçÏÂÁ½ÖÖÇéÐΣº

ÓÐÒºµªµÄÇéÐΣº
×éÖ¯ÑùÆ·ÀëÌåºó£¬£¬£¬£¬¿ìËÙÓÃRNase-freeÅäÖÆµÄÐÄÀíÑÎË®/PBSÏ´åªÑù±¾ÍâòµÄÎÛ×Õ£¬£¬£¬£¬²¢Îü¸ÉÍâòµÄÒºÌ壬£¬£¬£¬Ñ¸ËٵĽ«ÑùÌìÖ°¸îÉú³¤¿í¸ß<=0.5cmµÄС¿é£¨Ò»Ñùƽ³£ÖØÔ¼100mg£¬£¬£¬£¬²»¹ýÎÞÐ辫׼ÕÉÁ¿£¬£¬£¬£¬Ò»Ñùƽ³£ÐèÒª10¸öС¿é×óÓÒ£©£¬£¬£¬£¬½«Ñù±¾·ÅÈëÒѱê¼ÇºÃÃû³ÆÇÒÔ¤ÀäºÃµÄRnase-freeµÄÂÝÎÆ¹ÜÖУ¨²»Òª½«¸Ç×ÓÅ¡ËÀ£¬£¬£¬£¬ÒÔÃâ´ÓÒºµªÖÐÈ¡³öÊ±ÆÆË飩£¬£¬£¬£¬Ñ¸ËÙͶÈëÒºµªÖÐËÙ¶³>=1h£¬£¬£¬£¬È»ºóÈ¡³öÖÃÓÚ-80¡æÉúÑÄ£¬£¬£¬£¬¸É±ùÔËÊä¡£¡£¡£¡£¡£¡£

ûÓÐÒºµªµÄÇéÐΣº
Ìáǰ׼±¸ºÃRNase-freeµÄ1.5mLµÄEP¹Ü£¬£¬£¬£¬ÏòÆäÖмÓÈë1mLµÄRNAfixer¡£¡£¡£¡£¡£¡£
×éÖ¯ÑùÆ·ÀëÌåºó£¬£¬£¬£¬¿ìËÙÓÃRNase-freeÐÄÀíÑÎË®/PBSÏ´åªÑù±¾ÍâòµÄÎÛ×Õ£¬£¬£¬£¬²¢Îü¸ÉÍâòµÄÒºÌ壬£¬£¬£¬Ñ¸ËٵĽ«ÑùÌìÖ°¸îÉú³¤¿í¸ß<=0.5cm£¬£¬£¬£¬Ô¼Íã¶¹¾ÞϸµÄС¿é£¨Ò»Ñùƽ³£ÖØÔ¼100mg£¬£¬£¬£¬²»¹ýÎÞÐ辫׼ÕÉÁ¿£¬£¬£¬£¬Ò»Ñùƽ³£ÐèÒª10¸öС¿é×óÓÒ£©£¬£¬£¬£¬È»ºóͶÈëÌáǰ׼±¸ºÃµÄ1.5mLµÄEP¹ÜÖУ¬£¬£¬£¬Ê¹Ñù±¾ÍêÈ«½þûÔÚÒºÌåÖУ¬£¬£¬£¬È»ºóÖÃÓÚ-80¡æÖÐÉúÑÄ£¬£¬£¬£¬¸É±ùÔËÊä¡£¡£¡£¡£¡£¡£
×¢ÖØ£ºÊµÑé²Ù×÷Àú³ÌÖÐÇëÎñ±ØÈ·±£ÎÞRNAøÎÛȾ¡£¡£¡£¡£¡£¡£

2.m6A¼ì²âÒªÁìÓÐÄÄЩ£¬£¬£¬£¬Ö»ÄÜÓòâÐòµÄÒªÁìÀ´¼ì²âÂ𣿣¿

¶¨Á¿ÒªÁ죺LC-MS/MS¡¢EpiQuik m6A RNA Methylation Quantification Kit£¨±ÈÉ«·¨£©
¸ßͨÁ¿²âÐò£ºm6A-seq£¨MeRIP-seq£©¡¢miCLIP-seq
¶¨Á¿ÒªÁìÖ»Äܼì²âÕûÌåm6Aˮƽ£¬£¬£¬£¬ÎÞµ¥¼î»ùÇø·ÖÂÊ£»£»£»¿ÉÊDzâÐò·½¹æÔòûÓдËÏÞÖÆ¡£¡£¡£¡£¡£¡£Äú¿ÉÒÔÆ¾Ö¤ÊµÑéµÄÏêϸÐèÇóÑ¡Ôñ¶ÔÓ¦µÄ¼ì²âÒªÁì¡£¡£¡£¡£¡£¡£



 

ATAC-seq
 

ÔÚÓÐÏÞµÄϸ°ûºË¿Õ¼äÖУ¬£¬£¬£¬»ùÒò×éµÄ´ó²¿·ÖÊÇϸÃÜÕÛµþµÄ£¬£¬£¬£¬½öÁôÏÂÐèҪת¼µÄ²¿·ÖÊÇ¿ª·ÅµÄ¡£¡£¡£¡£¡£¡£»£»£»î»¯µÄµ÷¿ØÐòÁÐÉÏÁ¬ÏµÓÐת¼Òò×Ó£¬£¬£¬£¬×ªÂ¼Òò×Ó»áÕÐļÆäËûÂÑ°×Æô¶¯»ùÒòת¼¡£¡£¡£¡£¡£¡£ÈËÌåÄÚÓÐЩ»ùÒòÏÕЩһֱ´¦ÓÚ¿ªÆô״̬£¬£¬£¬£¬ÓÐЩ»ùÒòÓùýÖ®ºó¾Í±»ÏÐÖÃÔÚÒ»±ß£¬£¬£¬£¬ËüÃǵĻîÐÔ¶¼´¦ÓÚÑÏ¿áµÄµ÷¿ØÖ®Ï¡£¡£¡£¡£¡£¡£ATAC-seq£¨Assay for Transposase-Accessible Chromatin with high throughput sequencing£©£¬£¬£¬£¬Ê¹ÓÃDNAת×ùøÁ¬Ïµ¸ßͨÁ¿²âÐòÊÖÒÕ£¬£¬£¬£¬À´Ñо¿È¾É«ÌåµÄ¿É½øÈëÐÔ¡£¡£¡£¡£¡£¡£ATAC-seq Ö»ÐèÒªºÜÉÙµÄϸ°û¾ÍÄÜÅжϻùÒò×éÖÐËùÓлîÔ¾µÄµ÷¿ØÐòÁС£¡£¡£¡£¡£¡£
 
ÉúÎïÐÅϢѧÆÊÎöÄÚÈÝ

UG»·Çò¡¤(ÖйúÇø)¹Ù·½ÍøÕ¾


 

Chip-seq
 

Á¬ÏµÈ¾É«ÖÊÃâÒß¹²³ÁµíÊÖÒÕ£¨ChIP£©ºÍ¸ßͨÁ¿²âÐòÊÖÒÕ£¬£¬£¬£¬¶ÔÄ¿µÄÂѰ×Á¬ÏµµÄ DNA Ƭ¶Ï¾ÙÐвâÐò£¬£¬£¬£¬Äܹ»¸ßЧµØÔÚÈ«»ùÒò×鹿ģÄÚ¼ì²âÓë×éÂѰ×ÐÞÊΡ¢×ªÂ¼Òò×ӵȻ¥×÷µÄ DNA Çø¶Î¡£¡£¡£¡£¡£¡£
 
ÉúÎïÐÅϢѧÆÊÎöÄÚÈÝ

UG»·Çò¡¤(ÖйúÇø)¹Ù·½ÍøÕ¾


 

Cut & tag
 

CUT&Tag£¨Cleavage Under Targets and Tagmentation£©ÊÖÒÕ³¹µ×¸Ä±äÁËChIP-seqʵÑéµÄϸ°ûÁ¿ÐèÇ󣬣¬£¬£¬Ê¹Æä´ÓÔ­ÏȵÄ10,000¸ö´ó·ù½µµÍµ½ÁË60¸ö£¬£¬£¬£¬ÉõÖÁµ¥¸öϸ°û£¬£¬£¬£¬ÕâÎÞÒÉÊǶÔÉúÎïѧÑо¿ÁìÓòµÄÒ»´ÎÖØ´óÍ»ÆÆ¡£¡£¡£¡£¡£¡£CUT&TagÊÖÒյķºÆð£¬£¬£¬£¬²»µ«¼«´óµØÌá¸ßÁËʵÑéµÄ¿ÉÐÐÐÔºÍЧÂÊ£¬£¬£¬£¬¸üÔڹŰåChIP-seqʵÑéÖб£´æµÄÐÅÔë±ÈºÍÊý¾ÝÖØ¸´ÐÔµÈÎÊÌâ·½ÃæÊµÏÖÁËÖʵı¼ÌÚ¡£¡£¡£¡£¡£¡£

CUT&TagÊÖÒÕÊÇÒ»ÖÖË¢ÐÂÐÔµÄÂѰ×ÖÊ-DNA»¥×÷Ñо¿ÒªÁ죬£¬£¬£¬ÆäÆæÒìÖ®´¦ÔÚÓÚËü²»ÐèҪʹÓÃÃâÒß¹²³Áµí£¬£¬£¬£¬¶øÊÇͨ¹ýÕë¶Ô°ÐÂѰ׵Ŀ¹ÌåºÍProtein AµÄ½éµ¼£¬£¬£¬£¬ÀÖ³ÉʵÏÖÁËTn5ø£¨ÒÑÓëProtein AÈںϣ©ÔÚÇиîDNAƬ¶ÏµÄͬʱ£¬£¬£¬£¬ÔÚÐòÁÐÁ½Í·Ìí¼Ó²âÐòÌÖÂÛ¡£¡£¡£¡£¡£¡£¾­PCRÀ©Ôöºó£¬£¬£¬£¬¿ÉÒÔÖ±½ÓÌìÉúÓÃÓÚ¸ßͨÁ¿²âÐòµÄÎĿ⡣¡£¡£¡£¡£¡£

 
UG»·Çò¡¤(ÖйúÇø)¹Ù·½ÍøÕ¾
 
ÉúÎïÐÅϢѧÆÊÎöÄÚÈÝ

UG»·Çò¡¤(ÖйúÇø)¹Ù·½ÍøÕ¾

Copyright ? UG»·Çò    µØµã£ºÉϺ£ÊÐÆÖ¶«ÐÂÇø¹ú¼ÊÒ½Ñ§Ô°Çø×ÏÆ¼Â·908Ū19ºÅÂ¥

UG»·Çò¡¤(ÖйúÇø)¹Ù·½ÍøÕ¾

µã»÷ѯ¼Û

¡¾ÍøÕ¾µØÍ¼¡¿